Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...
Medical Device Network on MSN6m
Tumour-on-chip model could help discover pancreatic cancer therapiesProfessor Teusch and Dynamic42 set out their work in one of the most challenging cancers, with PDAC being the most common and lethal form of pancreatic cancer. A major cause of it ...
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
ZME Science on MSN15h
A Simple Blood Test Called PAC-MANN Could Detect Pancreatic Cancer Early and Save Thousands of LivesA new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...
According to the American Cancer Society, people diagnosed with pancreatic cancer have a 13% chance of living five years ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...
The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...
Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback